Benzinga’s Top Pre- Market Gainers (SENO, TTWO, RIMM, SMOD, CRME)

SenoRx, Inc. (NASDAQ: SENO) rose 21.54% to $6.15 in the pre-market session after SenoRx, Inc. announced that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic, Inc., Cytyc Corp., and Hologic L.P. (Hologic) in the U.S. District Court. Yesterday, SENO closed at $5.06. The 52-week trading range for SENO is $2.30 - $5.40.

Take-Two Interactive Software, Inc. (NASDAQ: TTWO) has climbed up 13.70% to $8.25 in the pre-market session. TTWO yesterday reported a fourth-quarter net loss of $22 million, or $0.28 a share from a net loss of $15 million or $0.20 a share from the same quarter last year. While, net revenue was $343.4 million as compared to $323.4 million in a year ago period. So far in 2009, TTWO gained over 9%.

Research In Motion Limited (USA) (NASDAQ: RIMM) has jumped over 11% to $70.40 after it earned $628.4 million, or $1.10 a share, from $396.3 million, or $0.69 share, from the same quarter last year. Total revenue for the third quarter was $3.92 billion, as compared to $2.78 billion in the year ago period. So far in 2009, RIMM gained over 55%. RIMM closed at $63.46 in the last trading session.

SMART Modular Technologies (WWH), Inc. (NASDAQ: SMOD) has moved up 12.42% to $5.43. Yesterday, SMART Modular announced that for 2Q2010, it estimates net sales to be in between $125 - $135 million, gross profit in the range of $30 - $32 million and net income per diluted share to be in between $0.06 - $0.08 on a GAAP basis. So far in 2009, SMOD gained over 210%.

CARDIOME PHARMA CORP (NASDAQ: CRME) has surged 8.04% to $4.30. Yesterday, CARDIOME PHARMA announced that the Phase 3 European Comparator Study evaluating vernakalant (iv) versus amiodarone met its primary endpoint. The 52-week trading range for CRME is $2.57 - $5.58. Yesterday, CRME closed at $3.98.